Journal Article Epublish 7 citations
PubMed: 35484651 DOI: 10.3324/haematol.2022.280637
Low-dose tyrosine kinase inhibitors in patients with chronic myeloid leukemia: a retrospective study in China.
Haematologica 107(8):1966-1970
Authors: Yilin Chen, Zelin Liu, Jing Zou, Danyu Wang, Wenjuan He, Li Meng, Fanjun Cheng, Yanli Zhang, Weiming Li
Affiliations
- Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei.
- Institute of Hematology,Huazhong University of Science and Technology Union Shenzhen Hospital, Guangdong Medical University, Shenzhen, Guangdong.
- Institute of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei.
- Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei.
- Department of Hematology, the Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan.
- Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei.
Abstract
Not available.
MeSH
Protein-Tyrosine Kinases, Hematology, Retrospective Studies, Leukemia, Myelogenous, Chronic, Bcr-Abl Positive, Leukemia, Myeloid